Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Lutronic's dual pulse Q-Switched Nd:Yag laser receives FDA approval

Lutronic : 27 May, 2008  (New Product)
Lutronic, one of the world's leading developers and manufacturers of medical laser systems, has received FDA clearance to market its Spectra VRM III.
The dual pulse Q-Switched Nd:Yag laser is the feature-rich successor to the Spectra VRM II. The laser produces four wavelengths (1064nm, 532nm, 585nm, 650nm) in Q-switched nanosecond pulse.

The laser is specifically designed to treat a wide array of dermatological and aesthetic conditions, including dermal and epidermal pigmented lesions, multicolour tattoos, melasma, and active acne. It further enables laser toning, and non-ablative photo-acoustic skin rejuvenation techniques.

The laser incorporates a dual pulse mode, which enables it to produce very short and quasi-long microsecond pulses. There are numerous advantages which result from the unique pulse characteristics not found in other lasers including extreme high peak power and a flat-top beam profile.

'The VRM III is extremely effective for the treatment of melasma. I have been achieving near 100 percent clearance on melasma treatment therapy. This is very impressive because melasma is traditionally thought to be treatment resistant. Further, the VRM has also been highly effective for the treatment of Post-Inflammatory Hyperpigmentation that may result as adverse side affects from other lasers or IPL treatments,' explained Dr Sooil Chun, the clinical professor of Yonsei University.

The company stated that further scientific works are being conducted for this treatment in an effort to collect additional empirical data for peer reviewed studies.

As tattoo removal is becoming one of the fastest-growing treatment groups, the four wavelength option offered by the VRM III laser enables treatment of a wide range of colours. The laser's flat-top beam profile provides increased patient comfort and reduced pinpoint bleeding, resulting in fewer side effects and significantly faster healing. The fine control of the 532 nm wavelength feature assures that epidermal lesions are treated with measurably less potential for PIH.

With an installed base of over 2000 VRM series units globally, the new VRM III is proving to be the workhorse system of choice for laser clinics around the world.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo